| Arzerra worldwide net sales in Q1 2012 totaled GBP 12.4 million Genmab expects royalty payment of DKK 22 million COPENHAGEN, Denmark, April 25, 2012 (GLOBE NEWSWIRE) -- Genmab A/S (Copenhagen:GEN) announced today that the Arzerra(r) (ofatumumab) net sales during the first quarter of 2012 were GBP 12.4 million (approximately DKK 110 million). This figure consists of net sales in the U.S. of GBP 9.0 million and in the rest of the world of GBP 3.4 million. Under the terms of the collaborat...continued GNMSF GNMSY |
Wednesday, April 25, 2012
Arzerra First Quarter 2012 Net Sales Figures
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment